Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency
Clinical trial NCT02604810 · COMPLETED
Trial details
- NCT number
- NCT02604810
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-09-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.